Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
Saved in:
Main Authors: | Fizza Abbas (Author), Daniel W. Coyne (Author) |
---|---|
Format: | Book |
Published: |
The Korean Society of Nephrology,
2019-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Refractory tertiary hyperparathyroidism after calcimimetics and delayed parathyroidectomy in a kidney transplant recipient
by: Ekamol Tantisattamo, et al.
Published: (2012) -
Long-term effectiveness of cinacalcet in non-dialysis patients with chronic kidney disease and secondary hyperparathyroidism
by: Ariadna Pérez-Ricart, et al.
Published: (2019) -
Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease
by: Yi-Chou Hou, et al.
Published: (2022) -
Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics
by: Nobuo Nagano, et al.
Published: (2005) -
Laboratory criteria for the persistence of secondary hyperparathyroidism in patients with chronic kidney disease
by: M. Urina, et al.
Published: (2020)